Gastrin-releasing peptide: A potential growth factor expressed in human neuroblastoma tumors

Current Surgery

Volumn 58, Issue 1, 2001, Pages 86-89

  Sebesta, James A ^a   Young, Amy ^a   Bullock, Jeff ^a   Moore, Katherine H ^a   Azarow, Kenneth ^a   Sawin, Robert S ^b  

^a MADIGAN ARMY MEDICAL CENTER   (United States)

^b SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

Author keywords

Ganglioneuroma; Gastrin releasing peptide; Gastrin releasing peptide receptor; Neuroblastoma; Neuropeptide

Indexed keywords

EID: 0008940093     PISSN: 01497944     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0149-7944(00)00437-2     Document Type: Article

References (19)

1. Bologna M., Festuccia C., Muzi P., Biodi L., Ciomei M. Bombesin stimulates growth of human prostatic cancer cells in vitro. Cancer. 63:1989;1714-1720.
2. Hajri A., Balboni G., Koenig M., Garaud J.C., Damg'e C. Gastrin releasing peptide in vivo and in vitro growth effects on an acinar pancreatic carcinoma . Cancer Res. 52:1992;3726-3732.
3. Naryan S., Guo J.S., Townsend C.M., Singh P. Specific binding and growth effects of bombesin related peptides on mouse colon cancer cells in vitro. Cancer Res. 50:1990;6772-6778.
4. Cuttitta F., Carney D.N., Mulshine J., et al. Bombesin-like peptides can function as autocrine growth factors in human small cell lung cancers. Nature. 316:1985;823-826.
5. Cuttitta F., Carney D.N., Mulshine J., Moody T.W., Minna J.D. Selective stimulation of small cell lung cancer clonal growth by bombesin and gastrin releasing peptide. Cancer Res. 47:1987;821-825.
6. Alexander R.W., Upp J.R., Poston G.J., Gupta V., Townsend C.M., Thompson J.C. Effects of bombesin on growth of human small cell lung carcinoma in vivo. Cancer Res. 48:1988;1439-1441.
7. Koppan M., Halmos G., Arencibia J.M., Lamharzi N., Schally A.V. Bombesin/gastrin releasing peptide antagonists RC-3095 and RC-3940-II inhibit tumor growth and decrease the levels and mRNA expression of epidermal growth factor receptors in H-69 small cell lung carcinoma. Cancer. 83:1998;1335-1343.
8. Miyazaki M., Lamharzi N., Schally A.V., et al. Inhibition of growth of MDA-MB-231 human breast cancer xenografts in nude mice by bombesin/gastrin-releasing peptide (GRP) antagonists RC-3940-II and RC-3095. Eur J Cancer. 34:1998;710-717.
9. Weber S., Zuckerman J.E., Bostwick D.G., et al. Gastrin releasing peptide is a selective mitogen for small cell lung carcinoma in vitro. J Clin Invest. 75:1985;306-309.
10. Radulovic S., Miller G., Schally A.V. Inhibition of growth of HT-29 human cancer xenografts in nude mice by treatment with bombesin/gastrin releasing peptide antagonist (RC-3095). Cancer Res. 51:1991;6006-6009.
11. Yano T., Pinski J., Groot K., Schally A.V. Stimulation by bombesin and inhibition by bombesin/gastrin releasing peptide antagonist RC-3095 of growth of human breast cancer cell lines. Cancer Res. 52:1992;4545-4547.
12. Sunday M.E., Kaplan L.M., Motoyama E., et al. Biology of disease gastrin releasing peptide (mammalian bombesin) gene expression in health and disease . Lab Invest. 59:1988;5-24.
13. Rozengurt E., Sinnett-Smith J. Bombesin stimulation of DNA synthesis and cell division in cultures of Swiss 3T3 cells. Proc Natl Acad Sci U S A. 80:1983;2936-2940.
14. Nagakawa O., Ogasawara M., Fujii H., et al. Effect of prostatic neuropeptides on invasion and migration of PC-3 prostate cancer cells. Cancer Lett. 133:1998;27-33.
15. Sawin R.S., Brockenbrough J., Ness J. Gastrin releasing peptide is an autocrine growth factor for human neuroblastoma. Surg Forum. 43:1992;606-608.
16. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidium-thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:1987;156-159.
17. Markwalder R., Reubi J.C. Gastrin releasing peptide receptors in the human prostate relation to neoplastic transformation . Cancer Res. 59:1999;1152-1159.
18. Kelly M.J., Linnoila R.I., Avis I.L., et al. Antitumor activity of a monoclonal antibody directed against gastrin releasing peptide in patients with small cell lung cancer. Chest. 112:1997;256-261.
19. Jungwirth A., Galvan G., Pinski J., et al. Luteinizing hormone releasing hormone antagonist Cetrorelix (sb-75) and bombesin antagonist RC-3940-II inhibit growth of androgen-independent PC-3 prostate cancer in nude mice. Prostate. 32:1997;164-172.